JP2021502347A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2021502347A5 JP2021502347A5 JP2020524573A JP2020524573A JP2021502347A5 JP 2021502347 A5 JP2021502347 A5 JP 2021502347A5 JP 2020524573 A JP2020524573 A JP 2020524573A JP 2020524573 A JP2020524573 A JP 2020524573A JP 2021502347 A5 JP2021502347 A5 JP 2021502347A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- period
- individual
- gemcitabine
- composition according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000008194 pharmaceutical composition Substances 0.000 claims 50
- SDUQYLNIPVEERB-QPPQHZFASA-N gemcitabine Chemical compound O=C1N=C(N)C=CN1[C@H]1C(F)(F)[C@H](O)[C@@H](CO)O1 SDUQYLNIPVEERB-QPPQHZFASA-N 0.000 claims 22
- 229960005277 gemcitabine Drugs 0.000 claims 22
- 238000012423 maintenance Methods 0.000 claims 16
- 206010005003 Bladder cancer Diseases 0.000 claims 8
- 208000007097 Urinary Bladder Neoplasms Diseases 0.000 claims 6
- 201000005112 urinary bladder cancer Diseases 0.000 claims 6
- 238000009115 maintenance therapy Methods 0.000 claims 5
- 210000003205 muscle Anatomy 0.000 claims 4
- 238000002560 therapeutic procedure Methods 0.000 claims 4
- 206010044412 transitional cell carcinoma Diseases 0.000 claims 3
- 210000000626 ureter Anatomy 0.000 claims 3
- 210000002700 urine Anatomy 0.000 claims 3
- 208000023747 urothelial carcinoma Diseases 0.000 claims 3
- 238000002512 chemotherapy Methods 0.000 claims 2
- DQLATGHUWYMOKM-UHFFFAOYSA-L cisplatin Chemical compound N[Pt](N)(Cl)Cl DQLATGHUWYMOKM-UHFFFAOYSA-L 0.000 claims 2
- 229960004316 cisplatin Drugs 0.000 claims 2
- 230000003387 muscular Effects 0.000 claims 2
- 239000000203 mixture Substances 0.000 claims 1
- 238000004321 preservation Methods 0.000 claims 1
- 238000011200 topical administration Methods 0.000 claims 1
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2023173773A JP2024009888A (ja) | 2017-11-08 | 2023-10-05 | ゲムシタビンを使用した膀胱癌の治療及び維持療法の方法 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762583394P | 2017-11-08 | 2017-11-08 | |
| US62/583,394 | 2017-11-08 | ||
| PCT/US2018/059698 WO2019094517A1 (en) | 2017-11-08 | 2018-11-07 | Methods of treatment and maintenance therapy for bladder cancer using gemcitabine |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023173773A Division JP2024009888A (ja) | 2017-11-08 | 2023-10-05 | ゲムシタビンを使用した膀胱癌の治療及び維持療法の方法 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2021502347A JP2021502347A (ja) | 2021-01-28 |
| JP2021502347A5 true JP2021502347A5 (https=) | 2022-01-04 |
Family
ID=66439297
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020524573A Pending JP2021502347A (ja) | 2017-11-08 | 2018-11-07 | ゲムシタビンを使用した膀胱癌の治療及び維持療法の方法 |
| JP2023173773A Pending JP2024009888A (ja) | 2017-11-08 | 2023-10-05 | ゲムシタビンを使用した膀胱癌の治療及び維持療法の方法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023173773A Pending JP2024009888A (ja) | 2017-11-08 | 2023-10-05 | ゲムシタビンを使用した膀胱癌の治療及び維持療法の方法 |
Country Status (18)
| Country | Link |
|---|---|
| US (3) | US10792297B2 (https=) |
| EP (1) | EP3706763A4 (https=) |
| JP (2) | JP2021502347A (https=) |
| KR (3) | KR102892737B1 (https=) |
| CN (1) | CN111787926A (https=) |
| AU (1) | AU2018366106B2 (https=) |
| BR (1) | BR112020008700A2 (https=) |
| CA (1) | CA3081839A1 (https=) |
| DO (1) | DOP2023000155A (https=) |
| EA (1) | EA202091143A1 (https=) |
| IL (2) | IL302714B1 (https=) |
| JO (1) | JOP20200124A1 (https=) |
| MA (1) | MA50581A (https=) |
| MX (2) | MX2020004771A (https=) |
| PE (1) | PE20210041A1 (https=) |
| PH (1) | PH12020550587A1 (https=) |
| SG (1) | SG11202003950WA (https=) |
| WO (1) | WO2019094517A1 (https=) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| LT4124339T (lt) | 2014-03-06 | 2025-11-10 | Vaisto įvedimo sistemos ir būdai šlapimo pūslės vėžiui gydyti gemcitabinu | |
| BR112020000832A2 (pt) | 2017-07-25 | 2020-07-21 | Taris Biomedical Llc | métodos para tratar metástase tumoral |
| JOP20200124A1 (ar) * | 2017-11-08 | 2020-05-20 | Taris Biomedical Llc | طُرق لعلاج سرطان المثانة باستخدام جيمسيتابين وعلاج مدوامة لذلك |
| WO2024092159A1 (en) * | 2022-10-28 | 2024-05-02 | Taris Biomedical Llc | Methods of treating bladder cancer with gemcitabine |
Family Cites Families (49)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4008719A (en) | 1976-02-02 | 1977-02-22 | Alza Corporation | Osmotic system having laminar arrangement for programming delivery of active agent |
| US4111203A (en) | 1976-11-22 | 1978-09-05 | Alza Corporation | Osmotic system with means for improving delivery kinetics of system |
| US6171298B1 (en) | 1996-05-03 | 2001-01-09 | Situs Corporation | Intravesical infuser |
| AU2003278881A1 (en) | 2002-09-23 | 2004-04-08 | Microchips, Inc. | Micro-reservoir osmotic release systems and microtube array device |
| CA2503193A1 (en) | 2002-10-22 | 2004-05-06 | The Biomerix Corporation | Method and system for intravesicular delivery of therapeutic agents |
| US8361490B2 (en) | 2004-09-16 | 2013-01-29 | Theracoat Ltd. | Biocompatible drug delivery apparatus and methods |
| DK1933810T3 (da) | 2005-08-11 | 2013-01-28 | Childrens Medical Center | Intravesikal lægemiddelafgivelsesindretning og fremgangsmåde |
| WO2007145704A2 (en) | 2006-04-24 | 2007-12-21 | Gloucester Pharmaceuticals | Gemcitabine combination therapy |
| EP1913962A1 (en) | 2006-10-22 | 2008-04-23 | Ophir Perelson | Expandable medical device for the treatment and prevention of cardiovascular diseases |
| KR101538748B1 (ko) | 2007-12-11 | 2015-07-22 | 메사추세츠 인스티튜트 오브 테크놀로지 | 이식형 의약 투여 장치와 방광과 기타 신체 낭 또는 내강의 치료 방법 |
| CA2720523C (en) | 2008-04-04 | 2013-12-17 | Lipella Pharmaceuticals, Inc. | Treatment of bladder dysfunction using liposomal botulinum toxin |
| EP2313122B1 (en) | 2008-07-17 | 2019-03-06 | Micell Technologies, Inc. | Drug delivery medical device |
| EA201170297A1 (ru) | 2008-08-09 | 2011-08-30 | Массачусетс Инститьют Оф Текнолоджи | Имплантируемое устройство для доставки лекарственных средств и способ лечения мужской мочеполовой системы и окружающих тканей |
| DK2445570T3 (da) | 2009-06-26 | 2013-02-25 | Taris Biomedical Inc | Implanterbare lægemiddelafgivelsesindretninger samt fremgangsmåder til deres fremstilling |
| US9017312B2 (en) | 2009-09-10 | 2015-04-28 | Taris Biomedical Llc | Implantable device for controlled drug delivery |
| US8721621B2 (en) | 2009-09-10 | 2014-05-13 | Taris Biomedical, Inc. | Systems and methods for deploying devices to genitourinary sites |
| PL3884988T3 (pl) | 2009-12-17 | 2025-09-08 | Taris Biomedical Llc | Urządzenie implantowalne z tolerancją wewnątrzpęcherzową |
| ES2732150T3 (es) | 2010-01-20 | 2019-11-20 | Urogen Pharma Ltd | Material y método para tratar cavidades internas |
| US20110218488A1 (en) | 2010-03-05 | 2011-09-08 | Taris Biomedical, Inc. | Systems and Methods for Implanting Devices in the Bladder and Other Genitourinary Sites |
| WO2011153009A1 (en) | 2010-06-02 | 2011-12-08 | Abraxis Bioscience, Llc | Methods of treating bladder cancer |
| EP3795121A1 (en) | 2010-08-05 | 2021-03-24 | TARIS Biomedical LLC | Ureteral stent drug delivery device |
| US9457176B2 (en) | 2010-10-06 | 2016-10-04 | Taris Biomedical Llc | Implantable drug delivery device with bladder retention feature |
| WO2012048114A1 (en) | 2010-10-06 | 2012-04-12 | Taris Biomedical, Inc. | Time-selective bioresorbable or collapsible drug delivery systems and methods |
| MX365807B (es) | 2010-10-27 | 2019-06-14 | Prometic Pharma Smt Ltd | Compuestos y composiciones para el tratamiento del cáncer. |
| WO2012079083A2 (en) | 2010-12-10 | 2012-06-14 | The Board Of Regents Of The University Of Nebraska | Hemodialysis catheter with displaceable tubes to disrupt a fibrous sheath |
| US8979797B2 (en) | 2010-12-16 | 2015-03-17 | Ams Research Corporation | High pressure delivery system and method for treating pelvic disorder using large molecule therapeutics |
| JP2014503554A (ja) | 2011-01-10 | 2014-02-13 | タリス バイオメディカル，インコーポレイテッド | 膀胱痛及び刺激性排尿の持続的治療の使用のためのリドカインレジメン |
| EP2670398B1 (en) | 2011-02-04 | 2017-06-07 | TARIS Biomedical LLC | Implantable device for controlled release of low solubility drug |
| US20150005595A1 (en) | 2011-12-30 | 2015-01-01 | Kibur Medical, Inc. | Implantable devices and methods for evaluation of active agents |
| CN104470535A (zh) | 2012-03-29 | 2015-03-25 | 阿尔托生物科学有限公司 | 用于治疗肿瘤的方法 |
| WO2013170069A1 (en) | 2012-05-09 | 2013-11-14 | Massachusetts Institute Of Technology | Medicament, method, and drug delivery device for treatment of ovarian cancer |
| MX367070B (es) | 2012-08-31 | 2019-08-05 | Taris Biomedical Llc | Sistemas de administracion de farmaco y metodos para el tratamiento de la prostata. |
| SG11201501424SA (en) | 2012-08-31 | 2015-03-30 | Taris Biomedical Llc | Drug delivery systems and methods for treatment of bladder cancer comprising oxaliplatin |
| JP2016508842A (ja) | 2013-03-05 | 2016-03-24 | タリス バイオメディカル エルエルシー | 装置の開口部を通じて制御された薬物放出のための薬物送達装置及び方法 |
| KR102557326B1 (ko) | 2013-03-15 | 2023-07-19 | 타리스 바이오메디컬 엘엘씨 | 약물-투과성 구성요소를 가지는 약물 전달 장치 |
| EP2968120B1 (en) | 2013-03-15 | 2026-01-14 | TARIS Biomedical LLC | Drug delivery devices and methods for drug delivery |
| CA2944480C (en) | 2013-04-10 | 2021-05-18 | Massachusetts Institute Of Technology | Local drug delivery devices and methods for treating cancer |
| DE102013103986A1 (de) | 2013-04-19 | 2014-10-23 | B. Braun Avitum Ag | Rezirkulationsvorrichtung eines extrakorporalen Blutbehandlungsgeräts |
| KR102385603B1 (ko) | 2013-08-19 | 2022-04-11 | 타리스 바이오메디컬 엘엘씨 | 다중 유닛 약물 전달 장치 및 방법 |
| US9215250B2 (en) | 2013-08-20 | 2015-12-15 | Janus Technologies, Inc. | System and method for remotely managing security and configuration of compute devices |
| EP3065807A1 (en) | 2013-11-05 | 2016-09-14 | TARIS Biomedical LLC | Osmotic drug delivery devices, kits, and methods |
| LT4124339T (lt) * | 2014-03-06 | 2025-11-10 | Vaisto įvedimo sistemos ir būdai šlapimo pūslės vėžiui gydyti gemcitabinu | |
| RU2591946C2 (ru) | 2014-06-24 | 2016-07-20 | Владимир Эдуардович Анников | Способ изготовления гелеобразного водосодержащего взрывчатого состава |
| KR20220061253A (ko) | 2014-06-26 | 2022-05-12 | 타리스 바이오메디컬 엘엘씨 | 탄성 폴리머-약물 매트릭스 시스템을 포함하는 방광내 약물 전달 장치 및 방법 |
| WO2016172704A1 (en) | 2015-04-23 | 2016-10-27 | Taris Biomedical Llc | Drug delivery devices with drug-permeable component and methods |
| CN118453872A (zh) | 2016-05-06 | 2024-08-09 | 塔里斯生物医药公司 | 治疗下尿路尿道上皮癌的方法 |
| BR112020000832A2 (pt) | 2017-07-25 | 2020-07-21 | Taris Biomedical Llc | métodos para tratar metástase tumoral |
| JOP20200124A1 (ar) | 2017-11-08 | 2020-05-20 | Taris Biomedical Llc | طُرق لعلاج سرطان المثانة باستخدام جيمسيتابين وعلاج مدوامة لذلك |
| CN112839653A (zh) | 2018-08-01 | 2021-05-25 | 塔里斯生物医药公司 | 使用曲司氯铵治疗膀胱过度活动症的方法 |
-
2018
- 2018-11-07 JO JOP/2020/0124A patent/JOP20200124A1/ar unknown
- 2018-11-07 PE PE2020000538A patent/PE20210041A1/es unknown
- 2018-11-07 KR KR1020247025280A patent/KR102892737B1/ko active Active
- 2018-11-07 EP EP18875446.9A patent/EP3706763A4/en active Pending
- 2018-11-07 CN CN201880084854.9A patent/CN111787926A/zh active Pending
- 2018-11-07 WO PCT/US2018/059698 patent/WO2019094517A1/en not_active Ceased
- 2018-11-07 BR BR112020008700-9A patent/BR112020008700A2/pt unknown
- 2018-11-07 US US16/183,673 patent/US10792297B2/en active Active
- 2018-11-07 SG SG11202003950WA patent/SG11202003950WA/en unknown
- 2018-11-07 JP JP2020524573A patent/JP2021502347A/ja active Pending
- 2018-11-07 MX MX2020004771A patent/MX2020004771A/es unknown
- 2018-11-07 EA EA202091143A patent/EA202091143A1/ru unknown
- 2018-11-07 CA CA3081839A patent/CA3081839A1/en active Pending
- 2018-11-07 MA MA050581A patent/MA50581A/fr unknown
- 2018-11-07 IL IL302714A patent/IL302714B1/en unknown
- 2018-11-07 IL IL274343A patent/IL274343B2/en unknown
- 2018-11-07 KR KR1020207016209A patent/KR20200085822A/ko not_active Ceased
- 2018-11-07 KR KR1020257039507A patent/KR20250174098A/ko active Pending
- 2018-11-07 AU AU2018366106A patent/AU2018366106B2/en active Active
-
2020
- 2020-05-08 PH PH12020550587A patent/PH12020550587A1/en unknown
- 2020-07-13 MX MX2023007680A patent/MX2023007680A/es unknown
- 2020-09-02 US US17/010,648 patent/US12029749B2/en active Active
-
2023
- 2023-03-09 US US18/181,467 patent/US20230321129A1/en active Pending
- 2023-08-04 DO DO2023000155A patent/DOP2023000155A/es unknown
- 2023-10-05 JP JP2023173773A patent/JP2024009888A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2021502347A5 (https=) | ||
| JP2024015120A5 (https=) | ||
| JP2021512121A5 (https=) | ||
| IL320452A (en) | Combination therapy for prostate cancer | |
| JP2012506448A5 (https=) | ||
| RU2012106620A (ru) | Комбинации и способы введения терапевтических средств и комбинированной терапии | |
| JP2020516646A5 (https=) | ||
| JP2016530280A5 (https=) | ||
| JP2012067116A5 (https=) | ||
| ME02395B (me) | Kombinovana terapija sa antitumorskim alkaloidima | |
| JP2016515586A5 (https=) | ||
| RU2017134443A (ru) | Способ лечения с применением традипитанта | |
| JP2017516802A5 (https=) | ||
| JP2020523356A5 (https=) | ||
| RU2008152341A (ru) | Применение аллопуринола для лечения ладонно-подошвенной эритродизестезии | |
| HRP20250113T1 (hr) | Režim doziranja za gp100-specifični tcr - anti-cd3 scfv fuzijski protein | |
| JP2019530706A5 (https=) | ||
| JP2017537927A5 (https=) | ||
| JP2015522015A5 (https=) | ||
| JP2024016209A5 (https=) | ||
| JPWO2020250915A5 (https=) | ||
| RU2005126819A (ru) | Усовершенствованное лечение опухолей | |
| JP2016505050A5 (https=) | ||
| Katsumata | Dose-dense approaches to ovarian cancer treatment | |
| Ban et al. | Nicotinic Acid in the Treatment of Schizophrenias: Summary Statement Progress Report I Canadian Mental Health Association Collaborative Study |